Research statistics
Angiotensin (1-7) Analog research: publications and trials
At a glance
Publications, all years
88
Since 2002
Publications in 2026 so far
4
Through November 15, 2026
Human clinical research
0.0%
0 of 88 classified
Registered clinical trials
0
ClinicalTrials.gov
Randomized controlled trials
0
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
92.0%
70 animal · 11 in vitro · 0 computational
Records that only mention it
6
Not counted above
Status in the library: Research only.
What to keep in mind
- No human clinical publication is indexed: everything published so far is preclinical, a review or commentary.
- Fewer than three randomized controlled trials are indexed.
- More than 70% of the indexed publications are animal, cell or computational studies.
Publications by year
Angiotensin (1-7) Analog publications by year and evidence
Show the data
| Year | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Other and not yet classified | Total |
|---|---|---|---|---|
| 2002 | 1 | 0 | 0 | 1 |
| 2003 | 0 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 0 | 1 |
| 2005 | 2 | 1 | 0 | 3 |
| 2006 | 2 | 1 | 0 | 3 |
| 2007 | 4 | 0 | 0 | 4 |
| 2008 | 1 | 0 | 0 | 1 |
| 2009 | 1 | 0 | 0 | 1 |
| 2010 | 5 | 0 | 0 | 5 |
| 2011 | 1 | 0 | 0 | 1 |
| 2012 | 8 | 0 | 0 | 8 |
| 2013 | 7 | 0 | 0 | 7 |
| 2014 | 1 | 0 | 0 | 1 |
| 2015 | 3 | 0 | 0 | 3 |
| 2016 | 2 | 0 | 0 | 2 |
| 2017 | 1 | 0 | 0 | 1 |
| 2018 | 3 | 0 | 0 | 3 |
| 2019 | 6 | 0 | 0 | 6 |
| 2020 | 6 | 1 | 0 | 7 |
| 2021 | 8 | 0 | 1 | 9 |
| 2022 | 3 | 1 | 0 | 4 |
| 2023 | 3 | 0 | 0 | 3 |
| 2024 | 3 | 1 | 0 | 4 |
| 2025 | 5 | 0 | 0 | 5 |
| 2026 (to date) | 4 | 0 | 0 | 4 |
Study types
| Animal study | 70 |
|---|---|
| In vitro study | 11 |
| Review | 5 |
| Editorial, letter or other | 2 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Cardiovascular | 58 |
|---|---|
| Immune system | 17 |
| Neurological and mental health | 16 |
| Tissue repair | 11 |
| Gastrointestinal | 10 |
| Metabolic health | 7 |
| Endocrinology | 6 |
| Reproductive and sexual health | 6 |
| Cognitive health | 5 |
| Antimicrobial and infectious disease | 4 |
| Oncology | 4 |
| Obesity and weight management | 3 |
Registered clinical trials
A registration is not a result.
No registered trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
No human trial, systematic review or meta-analysis of Angiotensin (1-7) Analog is indexed.
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1-7) on the endothelium.
Hypertension (Dallas, Tex. : 1979) · December 1, 2002 · In vitro study · cited 199 times
PMID 12468568 · DOI 10.1161/01.hyp.0000037979.53963.8f · In vitro studies
- Angiotensin-(1-7) prevents development of severe hypertension and end-organ damage in spontaneously hypertensive rats treated with L-NAME.
American journal of physiology. Heart and circulatory physiology · February 1, 2006 · Animal study · cited 187 times
PMID 16403946 · DOI 10.1152/ajpheart.00632.2005 · Animal studies
- Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis.
Journal of immunology (Baltimore, Md. : 1950) · October 8, 2010 · Animal study · cited 182 times
PMID 20935211 · DOI 10.4049/jimmunol.1000314 · Animal studies
- Nonpeptide AVE 0991 is an angiotensin-(1-7) receptor Mas agonist in the mouse kidney.
Hypertension (Dallas, Tex. : 1979) · August 23, 2004 · Animal study · cited 175 times · open access
PMID 15326087 · DOI 10.1161/01.hyp.0000141438.64887.42 · Animal studies
- AVE 0991 attenuates oxidative stress and neuronal apoptosis via Mas/PKA/CREB/UCP-2 pathway after subarachnoid hemorrhage in rats.
Redox biology · September 28, 2018 · Animal study · cited 174 times · open access
PMID 30296700 · DOI 10.1016/j.redox.2018.09.022 · Animal studies
Latest publications
- Cross talk between SARS-CoV-2 and the angiotensin system: clinical implications.
American journal of physiology. Cell physiology · September 2, 2026 · In vitro study · cited 0 times
PMID 42684673 · DOI 10.1152/ajpcell.00786.2025 · In vitro studies
- Mas receptor activation promotes mitophagy and preserves neuronal function after traumatic brain injury.
Mitochondrion · August 6, 2026 · Animal study · cited 0 times
PMID 42562073 · DOI 10.1016/j.mito.2026.102200 · Animal studies
- The nonpeptide angiotensin-(1-7) mimic AVE0991 attenuates neuroendocrine and behavioral responses to chronic unpredictable stress.
Psychopharmacology · July 13, 2026 · Animal study · cited 0 times · open access
PMID 42440117 · DOI 10.1007/s00213-026-07126-4 · Animal studies
- Mas receptor activation regulates the functional phenotype of myocardial macrophages through the Akt/Nrf2 signaling pathway to alleviate sepsis-induced cardiomyopathy.
Journal of translational medicine · April 24, 2026 · Animal study · cited 1 times · open access
PMID 42032737 · DOI 10.1186/s12967-026-08171-5 · Animal studies
- Blood pressure reduction and anti-inflammatory macrophage augmentation attenuate uterine immune dysregulation and inflammation in mice with salt-sensitive hypertension.
Clinical science (London, England : 1979) · December 1, 2025 · Animal study · cited 0 times · open access
PMID 41055571 · DOI 10.1042/cs20255879 · Animal studies
- Role of G-protein-coupled receptor kinase 4 on the dysfunction of renal Mas receptor in hypertension.
PloS one · August 5, 2025 · Animal study · cited 0 times · open access
PMID 40763158 · DOI 10.1371/journal.pone.0329547 · Animal studies
- The Non-Peptide MAS-R Agonist AVE0991 Alleviates Colitis Severity in Mice and Exhibits an Additive Effect with Azathioprine.
International journal of molecular sciences · June 17, 2025 · Animal study · cited 0 times · open access
PMID 40565247 · DOI 10.3390/ijms26125784 · Animal studies
- Activation of central Angiotensin-(1-7)/Mas receptor alleviates synaptic damage in diabetes-associated cognitive impairment via modulating AKT/FOXO1/PACAP axis.
International journal of biological sciences · April 9, 2025 · Animal study · cited 8 times · open access
PMID 40303297 · DOI 10.7150/ijbs.99617 · Animal studies
- Angiotensin 1-7 and the Non-Peptide MAS-R Agonist AVE0991 Inhibit Breast Cancer Cell Migration and Invasion.
Biomedicines · February 24, 2025 · In vitro study · cited 1 times · open access
PMID 40149544 · DOI 10.3390/biomedicines13030567 · In vitro studies
- AVE0991 ameliorates dopaminergic neuronal damage in Parkinson's disease through HOTAIRM1/miR-223-3p/α-synuclein axis.
Scientific reports · November 1, 2024 · Animal study · cited 5 times · open access
PMID 39487232 · DOI 10.1038/s41598-024-76058-w · Animal studies
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: AVE0991
((TITLE_ABS:"AVE0991" OR CHEM:"AVE0991" OR TITLE_ABS:"AVE 0991" OR CHEM:"AVE 0991")) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). Angiotensin (1-7) Analog research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/ang-1-7-analog